Literature DB >> 27943468

Progression of subcortical atrophy in mild Parkinson's disease and its impact on cognition.

H Foo1, E Mak2, T T Yong1, M C Wen1, R J Chander1, W L Au1,3, Y Y Sitoh3,4, L C S Tan1,3, N Kandiah1,3.   

Abstract

BACKGROUND AND
PURPOSE: Mild cognitive impairment (MCI) is associated with pronounced grey matter atrophy in various brain regions. However, the association between atrophy patterns and progression from no cognitive impairment (NCI) to Parkinson's disease (PD)-MCI is not clearly known. We investigated the pattern and progression of atrophy in subcortical structures and its impact on cognition in patients with mild PD.
METHODS: Sixty-five patients with mild PD with baseline and longitudinal clinical and neuropsychological assessments, and structural magnetic resonance imaging scans were studied. Movement Disorder Society Task Force criteria were used to classify patients with PD into PD-NCI (n = 54) and PD-MCI (n = 11). Based on progression over time, those who remained without cognitive impairment were classified as PD-stable (n = 42) and those who converted to MCI over 18 months were classified as PD-converters (n = 12). FreeSurfer was used to measure cortical thickness and subcortical volumes at baseline and follow-up.
RESULTS: Parkinson's disease-MCI showed baseline thalamus atrophy and progressive atrophy in the thalamus, caudate, presubiculum, cornu ammonis 1 and 2-3, and significant memory and executive dysfunction compared with PD-NCI. PD-converters had greater accumbens atrophy at baseline and progressive atrophy in the thalamus, caudate and accumbens with dysfunctions in memory and executive domains.
CONCLUSIONS: Progression of cognitive impairment in non-demented PD is associated with a specific pattern of subcortical atrophy. Findings from this study will allow future studies to investigate in the role of subcortical structures as a biomarker for PD dementia.
© 2016 EAN.

Entities:  

Keywords:  Parkinson's disease; cognitive impairment; subcortical atrophy

Mesh:

Year:  2016        PMID: 27943468     DOI: 10.1111/ene.13205

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  15 in total

1.  Statistically Defined Parkinson's Disease Executive and Memory Cognitive Phenotypes: Demographic, Behavioral, and Structural Neuroimaging Comparisons.

Authors:  Samuel J Crowley; Guita Banan; Manish Amin; Jared J Tanner; Loren Hizel; Peter Nguyen; Babette Brumback; Katie Rodriguez; Nikolaus McFarland; Dawn Bowers; Mingzhou Ding; Thomas A Mareci; Catherine C Price
Journal:  J Parkinsons Dis       Date:  2021       Impact factor: 5.568

Review 2.  Meta-Analysis of Cognition in Parkinson's Disease Mild Cognitive Impairment and Dementia Progression.

Authors:  Elizabeth R Wallace; Suzanne C Segerstrom; Craig G van Horne; Frederick A Schmitt; Lisa M Koehl
Journal:  Neuropsychol Rev       Date:  2021-04-16       Impact factor: 7.444

Review 3.  Mild Cognitive Impairment in Parkinson's Disease-What Is It?

Authors:  Rimona S Weil; Alyssa A Costantini; Anette E Schrag
Journal:  Curr Neurol Neurosci Rep       Date:  2018-03-10       Impact factor: 5.081

4.  Striatal shape alteration as a staging biomarker for Parkinson's Disease.

Authors:  Maxime Peralta; John S H Baxter; Ali R Khan; Claire Haegelen; Pierre Jannin
Journal:  Neuroimage Clin       Date:  2020-05-19       Impact factor: 4.881

Review 5.  Can neuroimaging predict dementia in Parkinson's disease?

Authors:  Juliette H Lanskey; Peter McColgan; Anette E Schrag; Julio Acosta-Cabronero; Geraint Rees; Huw R Morris; Rimona S Weil
Journal:  Brain       Date:  2018-09-01       Impact factor: 13.501

6.  Changes in Cortical Thickness in Patients With Early Parkinson's Disease at Different Hoehn and Yahr Stages.

Authors:  Yuyuan Gao; Kun Nie; Mingjin Mei; Manli Guo; Zhiheng Huang; Limin Wang; Jiehao Zhao; Biao Huang; Yuhu Zhang; Lijuan Wang
Journal:  Front Hum Neurosci       Date:  2018-11-27       Impact factor: 3.169

7.  Neuroimaging in Parkinson's disease dementia: connecting the dots.

Authors:  Rimona S Weil; Joey K Hsu; Ryan R Darby; Louis Soussand; Michael D Fox
Journal:  Brain Commun       Date:  2019-07-08

8.  Progressive brain atrophy in Parkinson's disease patients who convert to mild cognitive impairment.

Authors:  Cheng Zhou; Xiao-Jun Guan; Tao Guo; Qiao-Ling Zeng; Ting Gao; Pei-Yu Huang; Min Xuan; Quan-Quan Gu; Xiao-Jun Xu; Min-Ming Zhang
Journal:  CNS Neurosci Ther       Date:  2019-07-06       Impact factor: 5.243

9.  Sleep disturbances and gastrointestinal dysfunction are associated with thalamic atrophy in Parkinson's disease.

Authors:  Flavia Niccolini; Heather Wilson; Beniamino Giordano; Konstantinos Diamantopoulos; Gennaro Pagano; Kallol Ray Chaudhuri; Marios Politis
Journal:  BMC Neurosci       Date:  2019-10-22       Impact factor: 3.288

10.  Ethical Issues in Intraoperative Neuroscience Research: Assessing Subjects' Recall of Informed Consent and Motivations for Participation.

Authors:  Anna Wexler; Rebekah J Choi; Ashwin G Ramayya; Nikhil Sharma; Brendan J McShane; Love Y Buch; Melanie P Donley-Fletcher; Joshua I Gold; Gordon H Baltuch; Sara Goering; Eran Klein
Journal:  AJOB Empir Bioeth       Date:  2021-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.